Renal Cancer - Results from #2340

Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma. November 27, 2020

A "Lymphocyte MicroRNA Signature" as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. November 27, 2020

Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma. November 26, 2020

Novel MicroRNA Binding Site SNPs and the Risk of Clear Cell Renal Cell Carcinoma (ccRCC): A Case-Control Study. November 26, 2020

An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study. November 26, 2020

Identification of an independent autophagy-gene prognostic index for papillary renal cell carcinoma. November 26, 2020

Urinary collecting system invasion on multiphasic CT in renal cell carcinomas: prevalence, characteristics, and clinical significance. November 25, 2020

Immunotherapeutic Targets and Therapy for Renal Cell Carcinoma. November 25, 2020

Establishment and Validation of a Prognostic Risk Model for Autophagy-Related Genes in Clear Cell Renal Cell Carcinoma. November 25, 2020

Improving segmentation accuracy of CT kidney cancer images using adaptive active contour model. November 24, 2020

Downregulation of long non-coding RNA DUXAP10 inhibits proliferation, migration, and invasion of renal cell carcinoma. November 24, 2020

Final results of a dose escalation protocol of stereotactic body radiotherapy for poor surgical candidates with localized renal cell carcinoma. November 24, 2020

Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies. November 23, 2020

Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing. November 23, 2020

Expression of T-cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma. November 23, 2020

Prospective geriatric assessment for perioperative risk stratification in partial nephrectomy. November 20, 2020

Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma. November 20, 2020

First-Line Pazopanib Treatment in Metastatic Renal Cell Carcinoma: Real-World Data From a Single Chinese Center. November 20, 2020

Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma. November 19, 2020

Robot-assisted partial nephrectomy: 7-year outcomes. November 19, 2020

Page 118 of 456